PHILADELPHIA, January 3, 2013 /PRNewswire/ --
The editorial leadership of The American Journal of Pathology ( AJP) passed to the direction of esteemed neuropathologist Kevin A. Roth, M.D., Ph.D. on January 1, 2013.
Dr. Roth holds the Robert and Ruth Anderson Endowed Chair in Pathology at the University of Alabama at Birmingham (UAB). Involved in experimental pathology research for nearly 30 years, he published his first paper in AJP while an M.D., Ph.D. student at Stanford University. Dr. Roth also possesses extensive editorial experience, having served as an Associate Editor for AJP since 2003 and as Editor-in-Chief of the Journal of Histochemistry and Cytochemistry from 2006 to 2010.
The AJP is the leading global forum for reporting quality original research on cellular and molecular mechanisms of disease. With over 100 years of history, the Journal is widely read by the pathology community and garners over 30,000 citations to its articles each year (Source: 2011 Journal Citation Reports). Notably, Dr. Roth is also currently serving as Special Editor of the AJP Centennial Project, a special review series to celebrate the centennial of the American Society for Investigative Pathology (ASIP), which owns AJP.Dr. Roth has served as a Councilor for ASIP from 2010 to 2012, and is currently the ASIP Vice President. His term as ASIP President begins in 2014. Regarding his editorial appointment, Dr. Roth stated, "It is a special honor to be named the new Editor-in-Chief of The American Journal of Pathology in this centenary year. AJP, the official journal of this esteemed society [ASIP], has historically been one of the most prestigious and frequently cited journals in the field of pathology, and it is my intent to enhance further the quality and recognition of the Journal." Dr. Roth completed his postdoctoral training at Washington University, where he rose to professor in the Division of Neuropathology, Department of Pathology and Immunology, and in the Department of Molecular Biology and Pharmacology. Dr. Roth moved to UAB in 2002 and served as Director of the Division of Neuropathology until his appointment as Chair of Pathology in 2008. Dr. Roth, a renowned researcher on the molecular regulation of neuronal cell death, was the founding director of the UAB Comprehensive Neuroscience Center, an interdisciplinary collaboration for neuroscience research, clinical care, and education. The long-term goals of Dr. Roth's own research are to understand the role of cell death in normal nervous system development and its significance in neuropathological conditions including nervous system neoplasia.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV